Back to top
more

Boston Scientific (BSX)

(Delayed Data from NYSE)

$75.57 USD

75.57
8,825,251

+0.57 (0.76%)

Updated May 31, 2024 03:59 PM ET

After-Market: $75.97 +0.40 (0.53%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Headquartered in Natick, MA and founded in 1979, Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments viz. Cardiovascular (39.6% of total revenue in 2019; up 10% organically from 2018), Rhythm and Neuro (28.1%; up 1%) and MedSurg (30.2%; up 10.6%).

Can Boston Scientific (BSX) Keep the Earnings Surprise Streak Alive?

Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results

The use of Abbott's (ABT) HeartMate 3 pump can efficiently prolong life -term and improve the quality of life for advanced heart failure patients.

Edwards Lifesciences Presents Positive Partner 3 Trial Data

Edwards Lifesciences (EW) expects SAPIEN 3 to gain FDA approval for the low-risk indication in late-2019.

Medtronic (MDT) Releases Encouraging Evalut TAVR Result

Medtronic's (MDT) clinical study data shows that the low-risk aortic stenosis patients have special characteristics as they tend to be younger and active compared with the higher-risk equivalents.

Boston Scientific (BSX) Rides on Acquisitions, Innovation

Boston Scientific (BSX) takes a big leap forward by closing the buyout of Millipede and inking a deal to purchase BTG plc.

Boston Scientific's EP Arm Gets a Lift From Study Success

The positive result regarding Boston Scientific's (BSX) LUMINIZE RF Balloon Catheter is expected to help the company further advance with the procedures to clinch a CE Mark for the instrument.

Boston Scientific's WATCHMAN FLX LAAC Device Gets CE Mark

Receipt of the CE Mark followed by a limited launch of the WATCHMAN FLX device in Europe is likely to drive top-line contributions from Boston Scientific's (BSX) IC suite.

Boston Scientific (BSX) Up 1.9% Since Last Earnings Report: Can It Continue?

Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Boston Scientific Benefits From New Buyouts & Product Launch

Boston Scientific's (BSX) closure of Millipede acquisition and its buyout agreement with BTG plc are major developments for the company.

Mark Vickery headshot

Top Stock Reports for Disney, Eli Lilly & U.S. Bancorp

Today's Research Daily features new research reports on 16 major stocks, including Disney (DIS), Eli Lilly (LLY) and U.S. Bancorp (USB).

Company News For Feb 7, 2019

Companies In The News are: CPRI,BSX,GM,SNAP

Bright Near-Term Outlook for Medical Instruments Industry

Growing medical awareness and economic prosperity have been enhancing the uptake of medical instruments in the emerging economies.

Boston Scientific (BSX) Beats on Q4 Earnings, Margins Dip

Boston Scientific (BSX) is leaving no stone unturned to strengthen its core businesses and invest in global markets, which accounted for the uptick in sales across all geographies.

Boston Scientific (BSX) Q4 Earnings and Revenues Beat Estimates

Boston Scientific (BSX) delivered earnings and revenue surprises of 5.41% and 0.11%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Can Boston Scientific (BSX) Q4 Earnings Fuel Overall Growth?

We are hopeful that Boston Scientific (BSX) will report a strong IC business globally in Q4, backed by an innovative portfolio and robust commercial teams.

Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VREX vs. BSX: Which Stock Is the Better Value Option?

VREX vs. BSX: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Boston Scientific, Southern, BNY, Schlumberger and Southwest

The Zacks Analyst Blog Highlights: Boston Scientific, Southern, BNY, Schlumberger and Southwest

Mark Vickery headshot

Top Analyst Reports for Boston Scientific, Southern Company & BNY Mellon

Today's Research Daily features new research reports on 16 major stocks, including Boston Scientific (BSX), Southern Company (SO) and BNY Mellon (BK).

Boston Scientific Gains on Impressive Preliminary Q4 Results

Boston Scientific's (BSX) solid top line is expected to be backed by growth across all segments and geographical regions in Q4.

Boston Scientific (BSX) to Buy Residual Shares of Millipede

Boston Scientific's (BSX) buyout of the leftover stake in Millipede will integrate the latter's IRIS Transcatheter Annuloplasty Ring System in the Structural Heart portfolio of the former.

HRC or BSX: Which Is the Better Value Stock Right Now?

HRC vs. BSX: Which Stock Is the Better Value Option?

Boston Scientific (BSX) Outpaces Stock Market Gains: What You Should Know

Boston Scientific (BSX) closed at $37.67 in the latest trading session, marking a +1.7% move from the prior day.

HRC or BSX: Which Is the Better Value Stock Right Now?

HRC vs. BSX: Which Stock Is the Better Value Option?

Boston Scientific (BSX) Outpaces Stock Market Gains: What You Should Know

Boston Scientific (BSX) closed at $34.60 in the latest trading session, marking a +1.62% move from the prior day.